{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:01:31Z","timestamp":1792026091177,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"am","delay-in-days":361,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA169121-01A1"],"award-info":[{"award-number":["R01CA169121-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009155","name":"Otsuka America Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ajog.2019.02.019","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T11:02:11Z","timestamp":1550055731000},"page":"571.e1-571.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian\u00a0cancer"],"prefix":"10.1016","volume":"220","author":[{"given":"Stephanie","family":"Cham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn M.","family":"St. Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June Y.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Tergas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0410-2595","authenticated-orcid":false,"given":"Cande V.","family":"Ananth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred I.","family":"Neugut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn L.","family":"Hershman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2019.02.019_bib1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","article-title":"What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?","volume":"103","author":"Chi","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000192407.04428.bb","article-title":"Aggressive surgical effort and improved survival in advanced-stage ovarian cancer","volume":"107","author":"Aletti","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.02.019_bib3","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study","volume":"25","author":"Winter","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejso.2008.01.005","article-title":"Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients","volume":"35","author":"Colombo","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ygyno.2009.07.014","article-title":"Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancer","volume":"116","author":"Tsolakidis","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ygyno.2005.07.112","article-title":"Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer","volume":"99","author":"Mourton","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ygyno.2006.06.028","article-title":"The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer","volume":"103","author":"Eisenhauer","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ygyno.2006.03.028","article-title":"Splenectomy as part of cytoreductive surgery in ovarian cancer","volume":"102","author":"Magtibay","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2005.08.027","article-title":"Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer","volume":"100","author":"Aletti","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ygyno.2009.03.011","article-title":"Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: a systematic review","volume":"114","author":"Gerestein","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ygyno.2011.08.027","article-title":"Defining the limits of radical cytoreductive surgery for ovarian cancer","volume":"123","author":"Wright","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ygyno.2011.06.031","article-title":"Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualization","volume":"123","author":"Langstraat","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2015.01.543","article-title":"Impact of age on 30-day mortality and morbidity in patients undergoing surgery for endometrial cancer","volume":"137","author":"Mahdi","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0b013e31822a6d56","article-title":"Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly","volume":"118","author":"Thrall","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.02.019_bib15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/IGC.0b013e3182980fac","article-title":"Perioperative morbidity and mortality in octogenarians with ovarian cancer","volume":"23","author":"Walters","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2019.02.019_bib16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/AOG.0b013e31826981de","article-title":"Effect of radical cytoreductive surgery on omission and delay of chemotherapy for advanced-stage ovarian cancer","volume":"120","author":"Wright","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.02.019_bib17","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2019.02.019_bib18","doi-asserted-by":"crossref","first-page":"676 e1","DOI":"10.1016\/j.ajog.2007.10.495","article-title":"Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer","volume":"197","author":"Aletti","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.02.019_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2015.10.025","article-title":"Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer","volume":"140","author":"Kumar","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ygyno.2007.09.020","article-title":"Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma","volume":"108","author":"Chi","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib21","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1097\/IGC.0b013e31822c7704","article-title":"Surgical risk score predicts suboptimal debulking or a major perioperative complication in patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer","volume":"21","author":"Stashwick","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2019.02.019_bib22","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2015.05.034","article-title":"Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer","volume":"138","author":"Suidan","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib23","doi-asserted-by":"crossref","first-page":"e010123","DOI":"10.1136\/bmjopen-2015-010123","article-title":"Predictors of mortality within 1 year after primary ovarian cancer surgery: a nationwide cohort study","volume":"6","author":"Orskov","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2019.02.019_bib24","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1245\/s10434-016-5680-7","article-title":"Trends in mortality after primary cytoreductive surgery for ovarian cancer: a systematic review and metaregression of randomized clinical trials and observational studies","volume":"24","author":"Di Donato","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00000658-199810000-00006","article-title":"The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program","volume":"228","author":"Khuri","year":"1998","journal-title":"Ann Surg"},{"key":"10.1016\/j.ajog.2019.02.019_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ajog.2019.02.019_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.ajog.2019.02.019_bib28","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jclinepi.2006.01.014","article-title":"Review: a gentle introduction to imputation of missing values","volume":"59","author":"Donders","year":"2006","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ajog.2019.02.019_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ygyno.2015.04.037","article-title":"Risk stratification and outcomes of women undergoing surgery for ovarian cancer","volume":"138","author":"Patankar","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ygyno.2016.02.015","article-title":"Evaluation of the performance of the ACS NSQIP surgical risk calculator in gynecologic oncology patients undergoing laparotomy","volume":"141","author":"Rivard","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib31","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/IGC.0000000000000378","article-title":"Evaluation of the National Surgical Quality Improvement Program Universal Surgical Risk Calculator for a gynecologic oncology service","volume":"25","author":"Szender","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2019.02.019_bib32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2019.02.019_bib33","doi-asserted-by":"crossref","first-page":"j5463","DOI":"10.1136\/bmj.j5463","article-title":"Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all cause mortality: quasi-experimental study","volume":"360","author":"Melamed","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2019.02.019_bib34","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1200\/JCO.2016.69.2962","article-title":"Laparoscopy to predict the result of primary cytoreductive surgery in patients with advanced ovarian cancer: a randomized controlled trial","volume":"35","author":"Rutten","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib35","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ygyno.2012.02.006","article-title":"Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy","volume":"125","author":"Rodriguez","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib36","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2014.09.005","article-title":"CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy","volume":"135","author":"Pelissier","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.02.019_bib37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s12885-017-3476-1","article-title":"A\u00a0novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy","volume":"17","author":"Eoh","year":"2017","journal-title":"BMC Cancer"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937819303606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937819303606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:34:14Z","timestamp":1762079654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937819303606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0002937819303606"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2019.02.019","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian\u00a0cancer","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2019.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}